Overview

A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to provide initial safety and tolerability data as well as to provide PK data on potential interactions when GW856553 and rosuvastatin are co-administered in healthy male adults
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Rosuvastatin Calcium